Skip to main content
. Author manuscript; available in PMC: 2019 Sep 14.
Published in final edited form as: N Engl J Med. 2019 Mar 14;380(11):1001–1011. doi: 10.1056/NEJMoa1806808

Figure 2. Kaplan–Meier Analysis of the Primary End Point.

Figure 2.

Shown are the percentages of patients who were free from the primary end point — the diagnosis of tuberculosis or death from tuberculosis or an unknown cause — among all the patients (Panel A), among those with a CD4+ count of 250 cells per cubic millimeter or less (Panel B), and among those with a CD4+ count of more than 250 cells (Panel C), according to the receipt of either a 1-month regimen of daily rifapentine plus isoniazid (1-month group) or 9 months of isoniazid alone (9-month group).